Kumar Neil
SEC insider (Form 3/4/5 filer). CIK 0001742485. Chief Executive Officer at BridgeBio Pharma, Inc. (BBIO) and 1 other issuer. 196 reported Form 4/5 transactions since Sep 2024; latest on Sep 17, 2026. Located in PALO ALTO, CA.
Companies Kumar Neil has filed insider reports for
- BridgeBio Pharma, Inc. (BBIO): Director, Officer, Chief Executive Officer
- BridgeBio Oncology Therapeutics, Inc. (BBOT): Director
Kumar Neil
CIK: 0001742485
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (196 total)
- Sep 17, 2026BBIO
BridgeBio Pharma, Inc.
SaleIndirect1.3K shares at avg. $69.57$89K - Sep 17, 2026BBIO
BridgeBio Pharma, Inc.
SaleIndirect8.7K shares at avg. $69.01$602K - Aug 19, 2026BBIO
BridgeBio Pharma, Inc.
SaleIndirect100 shares at avg. $85.65$9K - Aug 19, 2026BBIO
BridgeBio Pharma, Inc.
SaleIndirect8.1K shares at avg. $83.86$679K - Aug 19, 2026BBIO
BridgeBio Pharma, Inc.
SaleIndirect1.8K shares at avg. $84.69$152K - Aug 18, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect1.2K shares at avg. $83.77$100K - Aug 18, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect17.3K shares at avg. $82.21$1.4M - Aug 18, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect14.6K shares at avg. $82.99$1.2M - Aug 18, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect1.9K shares at avg. $81.15$154K - Aug 16, 2026BBIO
BridgeBio Pharma, Inc.
ExerciseDirect19.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 17, 2026 |  BBIO BridgeBio Pharma, Inc. | Sale | 1,279 | $69.57 | $88,980 | Indirect |
| Sep 17, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 8,721 | $69.01 | $601,868 | Indirect |
| Aug 19, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 100 | $85.65 | $8,565 | Indirect |
| Aug 19, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 8,100 | $83.86 | $679,256 | Indirect |
| Aug 19, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 1,800 | $84.69 | $152,436 | Indirect |
| Aug 18, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 1,199 | $83.77 | $100,444 | Direct |
| Aug 18, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 17,279 | $82.21 | $1,420,514 | Direct |
| Aug 18, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 14,602 | $82.99 | $1,211,852 | Direct |
| Aug 18, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 1,900 | $81.15 | $154,184 | Direct |
| Aug 16, 2026 | BBIO BridgeBio Pharma, Inc. | Exercise | 19,599 | - | $0 | Direct |
1-10 of 196 transactions